
Coldpure AM 75mg/5mg/10mg Tablet SR
Marketer
Unipure Biotech
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview Coldpure AM 75mg/5mg/10mg Tablet SR
Respireze AM 75mg/5mg/10mg Extended-Release Tablets combine medications to treat respiratory illnesses involving thick mucus. This offers relief from productive coughs associated with conditions such as asthma, bronchitis, and the common cold. Respireze AM should be taken as directed by your physician, with or without food. Dosage depends on individual needs and response. Continue treatment for the prescribed duration; premature discontinuation may lead to symptom recurrence and worsening condition. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include nausea, indigestion, dry mouth, flu-like symptoms, tiredness, and headache. These are usually temporary. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until effects are known. Alcohol should be avoided due to increased drowsiness. Prior to use, disclose any kidney or liver conditions to allow for appropriate dosage adjustment. Also inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Coldpure AM 75mg/5mg/10mg Tablet SR
Managing respiratory illnesses complicated by thick mucus.
Major Benefits of Coldpure AM 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Coldpure AM 75mg/5mg/10mg Extended-Release Tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Coldpure AM 75mg/5mg/10mg Tablet SR:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use Coldpure AM 75mg/5mg/10mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Coldpure AM 75mg/5mg/10mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
How Coldpure AM 75mg/5mg/10mg Tablet SR works:
Each Coldpure AM 75mg/5mg/10mg extended-release tablet combines ambroxol, levocetirizine, and montelukast to alleviate cold symptoms. Ambroxol, a mucolytic agent, facilitates mucus expulsion by thinning and liquefying phlegm. Levocetirizine, an antihistamine, targets allergic rhinitis manifestations such as nasal discharge, lacrimation, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby mitigating airway and nasal inflammation and improving symptom control.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Coldpure AM 75mg/5mg/10mg Tablet SR necessitates careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Coldpure AM 75mg/5mg/10mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Coldpure AM 75mg/5mg/10mg tablet is likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Coldpure AM 75mg/5mg/10mg Extended-Release Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Coldpure AM 75mg/5mg/10mg SR tablets. Dosage modification of Coldpure AM 75mg/5mg/10mg SR tablets may be necessary; physician consultation is advised. Coldpure AM 75mg/5mg/10mg SR tablets are contraindicated in patients experiencing severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Coldpure AM 75mg/5mg/10mg extended-release tablets. Dosage modification of Coldpure AM 75mg/5mg/10mg extended-release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Coldpure AM 75mg/5mg/10mg Tablet SR :
Should you forget a Coldpure AM 75mg/5mg/10mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Coldpure AM 75mg/5mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
